With Myah Ward’s
WORLD NEWS FOR LATIN AMERICA: Latin America, home to less than 10% of the world’s population, now accounts for about a portion of all coronavirus-related deaths worldwide.
The largest number is found in Brazil, but Mexico, the time when the most populous country in the region, is also in a bad position: it has the fifth number of deaths, more than 32,000, due to coronavirus and more than 275,000 cases shown. He is about to overtake Italy early in terms of deaths due to Covid.
South American Trump: Brazilian President Jair Bolsonaro is a big fan of President Donald Trump and has always tried to emulate the American leader. Like Trump, Bolsonaro is known for his nationalist rhetoric and open to the media.
But now it’s catching up with Trump in a less desirable way: Brazil is the country of the moment in the world to show cases of coronavirus and deaths. There are more than 1.7 million instances there and 68,000 deaths.
And it turns out that there is no effort to stop the virus in Brazil. Even after Bolsonaro tested positive for Covid-19 this week, he still rejects the pandemic.
He doesn’t wear a mask, and he calls the coronavirus a “small flu.” He is now being prosecuted for his mask when he informed reporters of his coronavirus diagnosis.
He posted on Facebook earlier this week how he takes hydroxychloroquine and advised it as a remedy for the virus. (Trump said in May that he was taking the malaria drug. But last month, the FDA revoked its emergency use authorization for the drug, saying the potential benefits did not outweigh the risks of physical fitness) to increase indigenous peoples’ access to more hospitals. beds and medical devices to fight Covid-19.
This is a regional challenge: Chile, a more complex economy with a more modern fitness system, has the fourth worst pandemic in the world, measured by capital-consistent infection rates, according to a STAT tracker. Peru is the ninth worst. Panama is the tenth. Brazil is the 11th. Peru and Chile have registered thousands of instances: lately they are the fifth and sixth countries in terms of the total number of instances shown, according to Johns Hopkins.
Mexico ranks 54th in line with infection rates per person, however, its death toll is alarming to non-consistent audiences. Today, Mexico has the sixteenth consistent with the per capita mortality rate of any country, according to Johns Hopkins University tracker. The idea that real numbers are much more consistent. Several media outlets have reported that the death toll in Mexico City may be 3 times more consistent than its federal government reports.
Today alone, two other countries have had prominent politicians announcing positive results. Bolivia’s acting president, Jeanine Aez, announced this afternoon that she had tested positive for coronavirus. Aez, a devoted conservative, said she was fine and felt strong. Bolivia has only 43,000 cases shown and more than 1,500 deaths. Meanwhile, Diosdado Cabello, Venezuela’s second-largest socialist leader, announced this afternoon on Twitter that he had a coronavirus.
Mexican president is hiding in Washington – Mexican President Andrés Manuel López Obrador took an ad flight to DC this week to meet with Trump, a move that many former Mexican and political analysts have called a detour from their lack of response. (Democrats in the United States have said the same thing about Trump.)
Obrador delegated maximum resolution of the virus to his undersecretary of health, while displaying his amulets as a protective shield opposed to the virus and continued across the country without a mask. Meanwhile, Mexican governors have called for stricter border restrictions to prevent Americans from entering and warned that Obrador’s resolve to start reopening the country last month can backfire, as in many U.S. states.
Stay away from the Inca Trail: Although everyone gets excited about a trip, don’t expect to be on a beach in Ipanema or explore Machu Picchu in the short term, even if you’re in a position to wear a mask and risk being fit. Brazil still bans foreigners from entering the country and Peru has not set a date to reopen the historic site. However, Americans are free to book a flight to lie down on a beach in Cancun at their own risk.
Welcome to POLITICO Nightly: Coronavirus Special Edition. Renu is out, but your inbox easily accepts recommendations and notes. Contact us: [email protected] or on Twitter at @renurayasam.
U.S. biopharmaceutical corporations are sharing their wisdom and resources more than ever to drive the progression of new drugs to combat COVID-19. They paint with doctors and hospitals in more than 1,100 clinical trials. Because science brings us back to normal. More.
REAPPEST SCHOOLS, NOT WHAT THERE IS – There’s a way to reopen American schools. This requires a transparent look at the data. This requires a balanced discussion of benefits and prices, for students, parents and educators. And it doesn’t look much like the path of America, writes virtual mag editor Zack Stanton.
“We run the threat of stifled balance by turning it into ‘people who need to reopen’ and ‘people who don’t need to reopen,’ says Emily Oster, an economist at Brown University. Oster, a writer of two best-selling books that brings a data-driven technique to fatherhood and pregnancy, fears that final schools will harm children’s education, harm the economy, harm parents, especially mothers, and exacerify the inequalities that the pandemic is already causing
She tells Stanton, ‘Part of what makes it difficult, and a component of why other people place unsightly economists in those discussions, is that at the end of the day, all those commitments will involve saying, ‘I’m willing to accept that threat to someone. Gym get advantages to get advantages from those others get advantages. ‘It’s kind of awkward to say viscerally, and I also find it uncomfortable. I’m a user as well as an economist. But one of the things I check to remind other people is that we do those calculations all the time. We allow other people to drive their cars, have pools and do all sorts of things that we know are threatening and that, in the case of driving, pose threats to others. As a society, we allowed some of these commitments, we might not think of them precisely that way.
Researchers are examining a century-old vaccine to see if it can offer limited protection against the coronavirus. Nightly’s Myah Ward talked to Jeffrey Cirillo, a professor of microbial pathogenesis and immunology at Texas A&M College of Medicine, about a U.S.-based trial he’s leading for the tuberculosis vaccine, also known as BCG. This conversation has been edited.
Why did you start with the COvid-19 TB vaccine?
When the pandemic began, we were all looking for other methods to expand new diagnoses, treatments and vaccines that could be used instead of a new virus in an immediate era.
And what we knew when we saw the clinical cases: we see this typhoon of cytokines, or out-of-control inflammation, and that advised us that if we could simply tip the balance of the immune reaction otherwise, we could decrease disease. And that advised the vaccine we’re talking about today: the BCG vaccine that is used internationally for tuberculosis. We use it in the United States to treat bladder cancer because it points to the immune reaction to broken cells.
So we went to the FDA and said, “This is already FDA approved for bladder cancer. Can we use it outside of MMA, for a goal that is not used for, to treat Covid-19?” received approval. It is given to 500 million young people worldwide. It is given at birth to very, very young children. Very few appearance effects, very safe. And then the consultation was, why not?
Tell me about the trial.
This is a randomized, blind, placebo-controlled trial. This is the maximum rigorous test. At the end of the test, we could launch a national immunization program.
This vaccine is the only one in phase four trials worldwide. So this is the last step before it can be used for other people nationally.
We are also conducting a parallel cognitive exam to evaluate the cognitive effects of Covid-19. Then we do MRI and cognitive tests from the beginning, before vaccination. And at the end of the test at six months, we will go back and compare the effects of the virus and vaccine with the effects at the end of the test.
We probably already have between 100 and 150 other people vaccinated. And in the next week or two, we’re going to probably move into the range of two hundred to three hundred. The overall test is approximately 1,800.
Can you tell us a little more about the cognitive effects of Covid-19 you mentioned?
During the 1918 pandemic, we saw the same kind of thing, a spike in Alzheimer’s and Parkinson’s disease, about five to ten years after the pandemic. And so, with Covid-19, we expect the same kind of thing. But this vaccine has the ability to do this kind of inflammatory response.
So is it the purpose of associating this vaccine with a Covid-19 vaccine, or is it something that will stop us until we have an approved vaccine in about a year?
I think it’s a bit of both. If you reduce mortality, let’s say we can cut mortality in half, it saves us time until we have a quick vaccine. But the other thing we know, I noticed with polio, papillomavirus and flu, by combining this vaccine with a quick vaccine, the vaccine will be more effective.
What about the outliers that are already this vaccine? Brazil, for example, uses it extensively, but faces accumulation in Covid-19 cases.
The United States has never been vaccinated with this vaccine. Therefore, we expect to see the greatest effect on the American population. What we do know with this vaccine is that it lasts from 2 to 3 years: the maximum effectiveness, the highest point of immune response, is about 2 to 3 years. People usually see pretty smart coverage for about 10 years, but after that it starts to decline. In Brazil, the vaccine is given at birth. For example, the maximum of other people who hire Covid-19, almaximum anywhere in the world, are between 20 and 30 years old. So, at least 10 years ago, when we expect to see efficiency.
Before the virus entered the United States, very few young people were shown to have contracted Covid-19. But in the United States, we’ve noticed this Kawasaki-type inflammatory syndrome. We think it’s probably because we’re not vaccinating in the United States. Children in other countries have opposed this inflammatory syndrome, while in the United States they have not.
If this vaccine is safe, why can’t we go on and start it now?
The main explanation for why is that we don’t have the production and production capacity to allow everyone to get drained. And right now, the vaccine is already saving lives in the United States for bladder cancer. Therefore, we do not need to deprive life-saving resources, unless we are 100 percent sure it will make a significant difference.
SCHOOL ADDRESSES – Congressional efforts to deliver its next coronavirus relief program face a new major obstacle: the national fight for the reopening of American schools. Expansive investment situations for schooling are likely to be a central detail of the upcoming package of more than $1 trillion, with unemployment benefits that soon expired and more stimulus controls, Congressional editors Sarah Ferris and Marianne LeVine write. While the federal government cannot establish procedures for local school districts, Republicans and Democrats are interested in using the program to shape how the country reopens schools for millions of students.
THE ZOOM PANEL – Eugene Daniels, Tim Alberta, Elena Schneider and Laura Baron-Lupez talk about Covid-19 disparities and evidence, and the ramifications of Thursday’s Supreme Court decisions on the most recent episode of Four Square.
Nightly asks: How do you think schools and day care centers will reopen this fall, if any? Let us know in our way and we’ll arrive with some of the answers in Friday’s edition.
VACATION TRAVEL – Tyler Weyant of Nightly writes:
Washington, as we have understood most exactly in recent weeks, is explained through its monuments: the lincoln memorial’s compliance columns, the dome that covers Thomas Jefferson, the obelisk commemorating the first president. But one monument is more beloved than any other through DC’s political elegance: August.
Yes, in August, when the national capital acquires the atmosphere of a French summer. On the banks of the Potomac, it would possibly make Louisiana’s subsoil rainy and warm, but why bother? The assaulted hordes went to their homes on the east coast, or in Cape Town or Mar-A-Lago. Whether you’re with them or stay behind, with Wi-Fi and a phone, paintings as hard as other people don’t realize you’re at your moment gin and tonic at 3 p.m.
Over the past few weeks, I’ve won requests from friends and a circle of family members asking me if I wanted to take a short trip. These are not giant cruises or prohibited trips in Europe, however, only stay within 3 hours, one possibility and look at another set of walls in another zip code. Any other summer, it would happen in the blink of an eye.
The elegance of other people who disperse from the swamp in August realizes that their typical August is also on the fence. The closest other people can get to a beach can be simply photographing them in Zoom. But, like the country that sends the maximum of those other people to Washington DC, we all have to make sacrifices in relation to our same old routines and amenities for the non-unusual good.
And there’s no slowdown. American biopharmaceutical corporations will continue to paint day and night until they defeat the coronavirus. Because science brings us back to normal.
Did I email you? Register here.